Scientific Book2024

Novel Pharmacological Therapies for Coeliac Disease

  • 7th March 2025
  • 2 min read

A Presentation You Shouldn’t Miss

If you or someone you know is affected by coeliac disease, you may find maintaining a gluten-free diet challenging - or perhaps you still experience symptoms despite strict adherence. You are not alone. Up to 30% of patients continue to struggle with symptoms even while following a gluten-free diet.

Coeliac patients and professionals with expertise in the disease shouldn’t miss this insightful presentation by Professor Detlef Schuppan, a leading expert in the field.

In this recorded talk from the AOECS Annual Conference 2024, he explores cutting-edge pharmacological therapies for coeliac disease, offering a comprehensive overview of novel treatment approaches that could transform disease management for those who continue to suffer despite dietary restrictions.

About Professor Detlef Schuppan

Professor Detlef Schuppan is a distinguished physician and scientist specialising in gastroenterology, immunology, and hepatology. He is widely recognised for his groundbreaking research on coeliac disease, gluten sensitivity, and fibrotic diseases. His work has significantly advanced our understanding of the disease, including identifying tissue transglutaminase (tTG) as the primary autoantigen in coeliac disease.

About the AOECS Annual Conference

The AOECS Annual Conference is a yearly key event organised by the Association of European Coeliac Societies (AOECS). It brings together national coeliac societies, researchers, policymakers, and industry representatives to discuss the latest developments in coeliac disease research, gluten-free food safety, and advocacy efforts.

The next AOECS Annual Conference will be held on October 17, 2025, in Brussels, Belgium.

 

See presentation here